WebIntermittent IV Injection Dilute 20 mg of famotidine injection to a total of 5 or 10 mL with 0.9% Sodium Chloride Injection or other compatible solution to give concentrations of 4 or 2 mg/mL, respectively. Inject appropriate dose over 2 minutes or more and at a rate of 10 mg/minute or less.[51456] Intermittent IV Infusion (vials) WebDec 15, 2024 · Effective with date of service Jan. 1, 2024, the Medicaid and NC Health Choice programs cover famotidine injection (Pepcid®) for use in the Physician Administered Drug Program (PADP) when billed with HCPCS code J3490 - Unclassified drugs. Strength/Package Size (s): Famotidine injection, 20 mg piggyback, 20 mg/2 mL …
Famotidine (Mylan Institutional LLC): FDA Package Insert, Page 4
WebPEPCID (famotidine) Injection is supplied as a sterile concentrated solution for intravenous injection. Each mL of the solution contains 10 mg of famotidine and the following … WebPEPCID (famotidine) Injection is supplied as a sterile concentrated solution for intravenous injection. Each mL of the solution contains 10 mg of famotidine and the following inactive ingredients: L-aspartic acid 4 mg, mannitol 20 mg, and Water for Injection q.s. 1 mL. The multidose injection also contains benzyl alcohol 0.9% added as preservative. peter rowan land of the navajo
FAMOTIDINE INJECTION, USP 20 mg/2mL - DailyMed
WebSep 3, 2024 · Famotidine Injection 10 mg/mL, is a preserved, clear, colorless solution and is supplied as follows: NDC 55390-028-10, 4 mL two dose vial, carton of 10. NDC 55390-027-01, 20 mL multidose vial, individually boxed. Storage. Store famotidine injection at 2° to 8°C (36° to 46°F). WebFeb 12, 2024 · Uses of Famotidine Injection Solution: It is used to treat or prevent GI (gastrointestinal) ulcers. It is used to treat gastroesophageal reflux disease ( GERD; acid reflux ). It is used to treat heartburn and sour stomach. It is used to treat syndromes caused by lots of stomach acid. It may be given to you for other reasons. WebJul 24, 2024 · Famotidine Injection 4 mL and 20 mL multiple dose vials contain the preservative benzyl alcohol. There have been reports of fatal ‘gasping syndrome’ in neonates (children less than one month of age) following the administration of intravenous solutions containing the preservative benzyl alcohol. Symptoms include a striking onset … peter rowan facebook